SCHEMBL4012772

SCHEMBL4012772

COC(=O)/C=C(/C)c1cccc(OC)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 1/20 0.59
CES1 P23141 1/20 0.59
PARP1 P09874 1/20 0.56
NPC1 O15118 8/20 0.54
RAB9A P51151 8/20 0.54
MTNR1A P48039 3/20 0.54
MTNR1B P49286 3/20 0.54
MEN1 O00255 1/20 0.53
KMT2A Q03164 1/20 0.53
ALDH1A1 P00352 3/20 0.52
SMN1; SMN2 Q16637 4/20 0.51
TSHR P16473 3/20 0.51
ABCG2 Q9UNQ0 1/20 0.51
NPSR1 Q6W5P4 1/20 0.50
TP53 P04637 2/20 0.49
MAPT P10636 1/20 0.49
HTT P42858 1/20 0.49
KCNK3 O14649 1/20 0.49
KCNK9 Q9NPC2 1/20 0.49
KDM4E B2RXH2 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4012777 1.00 CES2 (0.59) CES2CES1PARP1NPC1RAB9A
SCHEMBL17755036 1.00 CES2 (0.59) CES2CES1PARP1NPC1RAB9A
SCHEMBL28428039 0.85 CES2 (0.61) CES2CES1PARP1NPC1RAB9A
SCHEMBL4008579 0.85 CES2 (0.61) CES2CES1PARP1NPC1RAB9A
SCHEMBL4008578 0.85 CES2 (0.61) CES2CES1PARP1NPC1RAB9A
SCHEMBL11486610 0.85 CES2 (0.53) CES2CES1PARP1NPC1RAB9A
SCHEMBL11486614 0.85 CES2 (0.53) CES2CES1PARP1NPC1RAB9A
SCHEMBL10353153 0.84 CES2 (0.56) CES2CES1PARP1NPC1RAB9A
SCHEMBL12900045 0.83 KDM4E (0.58) NPC1RAB9AMEN1KMT2AALDH1A1
SCHEMBL986740 0.83 KDM4E (0.58) NPC1RAB9AMEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1963304-B2 ISOQUINOLINE DERIVATIVES MSD OSS BV (NL) 2015-05-13 EP disclosed
US-7618985-B2 Isoquinoline derivatives N.V. ORGANON (NL) 2009-11-17 US disclosed
EP-1963304-B1 ISOQUINOLINE DERIVATIVES ORGANON NV (NL) 2009-06-24 EP disclosed
EP-1963304-A1 ISOQUINOLINE DERIVATIVES N.V. Organon (NL) 2008-09-03 EP disclosed
WO-2007065916-A1 ISOQUINOLINE DERIVATIVES N.V. ORGANON (NL) 2007-06-14 WO disclosed
US-20070135479-A1 Isoquinoline derivatives N.V. ORGANON (NL) 2007-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070135479-A1 Isoquinoline derivatives ROCK1, ROCK2, RHOA CES2 3467/4885CES1 380/4885PARP1 1819/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.